Targeting METTL3 protects against acetaminophen-induced liver injury through HAPTOGLOBIN/CD163 macrophage axis
Science Advances · 20.11.2026 · 12 (47)
DOI: 10.1126/sciadv.aeh6209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.11.2026. Verfasst von Huaxin Chen und 20 weiteren Autor:innen. Die Arbeit nennt 92 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China Stem Cell and Translational Research, Guangzhou Science and Technology Program key projects.
Abstract (Originalsprache)
Acetaminophen (APAP) overdose is the most common cause of drug-induced liver injury (DILI), with limited treatment options. N 6 -methyladenosine (m 6 A) is the most abundant internal epitranscriptomic modification in eukaryotic RNAs and is involved in various physiological and pathological processes, serving as a potential therapeutic target for many diseases. However, little is known about the role of m 6 A in DILI. Here, we found that intrahepatic expression of Methyltransferase-like 3 (METTL3), the core catalytic subunit of RNA m 6 A methyltransferase complex, was elevated in patients with DILI and mouse DILI models. Hepatocyte-specific knockout of METTL3, achieved via either Alb-Cre ERT2 –driven recombination or adeno-associated virus (AAV)–mediated delivery of Cre, significantly protected from APAP-induced hepatotoxicity in both male and female mice. Mechanistically, hepatic METTL3 deficiency reduced m 6 A deposition on acute-phase protein haptoglobin ( Hp ) transcripts and promoted Hp transcription and translation in hepatocytes. Increased HP secreted by hepatocytes bound to its receptor CD163, expressed explicitly on macrophages, and induced highly phagocytic and anti-inflammatory polarization of macrophages, finally reducing APAP-induced hepatic injury. Moreover, two different METTL3 inhibitors, JNJ64619178 and STM2457, effectively alleviated APAP-induced liver injury. Our study thus demonstrated that hepatic inhibition of METTL3 protected against APAP-induced liver injury by promoting the cross-talk between hepatocytes and macrophages through HP/CD163, underscoring the potential of targeting METTL3 as a promising therapy for APAP overdose.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China Stem Cell and Translational Research
- Guangzhou Science and Technology Program key projects
- Xinjiang Autonomous Region Regional Collaborative Innovation Special Project
- Guangdong Provincial Science and Technology Department
- Fundamental Research Funds for the Central Universities, Sun Yat-sen University
Zitieren
APA
Chen, H., Tu, S., Cui, B., Zeng, Z., Chen, X., Dong, S., Li, Y., Yu, S., Liu, X., Xiao, R., Guo, J., Liang, X., Pan, L., Chu, J., Huang, Y., Liu, C., Lv, G., Zhang, Y., Chen, W., …, & Xu, Y. (2026). Targeting METTL3 protects against acetaminophen-induced liver injury through HAPTOGLOBIN/CD163 macrophage axis. Science Advances, 12(47). https://doi.org/10.1126/sciadv.aeh6209
Vancouver
Chen H, Tu S, Cui B, Zeng Z, Chen X, Dong S, et al. Targeting METTL3 protects against acetaminophen-induced liver injury through HAPTOGLOBIN/CD163 macrophage axis. Science Advances. 2026;12(47). doi:10.1126/sciadv.aeh6209
BibTeX
@article{Chen2026,
author = {Chen, Huaxin and Tu, Silin and Cui, Bo and Zeng, Zhancheng and Chen, Xuanyong and Dong, Shuai and Li, Yanli and Yu, Shanshan and Liu, Xiao and Xiao, Ruiqi and Guo, Jing and Liang, Xiaoqi and Pan, Lijie and Chu, Jiajie and Huang, Yiju and Liu, Chang and Lv, Guo and Zhang, Yiwang and Chen, Wenjie and Zhang, Qi and Xu, Yan},
title = {Targeting METTL3 protects against acetaminophen-induced liver injury through HAPTOGLOBIN/CD163 macrophage axis},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {47},
doi = {10.1126/sciadv.aeh6209}
}
EUVIMED